Markets
Many of these digital funds will continue to deliver reasonable returns from a 3-5 year perspective: Tarun Birani of TBNG Capital
India's stock benchmarks opened higher, aided by gains in auto stocks. Sensex, Nifty erased opening gains dragged by metal stocks
Track the latest developments around oil here.
Follow the latest subscription updates from day 2 of eMudhra IPO.
Here's all you need to know about what's moving markets.
According to Goldman Sachs, Paytm’s lending business has been scaling up well, while maintaining good credit metrics.
Divi's Labs net profit jumped 78% year-on-year to Rs 895 crore in the quarter ended March.
Get ready for a fresh slump in the world’s most-watched stock index.
Jalan says she’s growing more cautious in her investment picks on concerns about valuations and multiple uncertainties.
Rupee rises 4 paise to 77.66 against US dollar in early trade
Shree Cement's valuation, though corrected, are still at a premium to market leader UltraTech Cement's, analysts say.
Morgan Stanley initiated coverage on Bharti Airtel with a price target of Rs 840 apiece, an implied upside of 25%.
Every rise, for now, is a bear-phase rally. Typically, they will be swift and strong but very short-lived, writes CK Narayan.
Tesla is limping to the finish line, as the stock’s 14% decline this week makes it the second-biggest drag on the S&P 500 Index.
Seven weeks of losses for American stocks have left Wall Street prognosticators as lost as they were during the coronavirus crash.
To Wall Street analysts, it’s another twist but for market historians, it can’t help but ring a faint, bullish bell.
Follow the latest subscription updates from day 3 of Ethos IPO.
Follow the latest subscription updates from day 1 of eMudhra IPO.
But analysts are optimistic on Godrej Consumer's long-term growth perspective, on both revenue and margin fronts.
Here’s what brokerages have to say about Lupin’s fourth-quarter performance.
Shares of Prudent Corporate Advisory Services Ltd. declined after listing at a 4.7% premium to its IPO price on debut.
Here’s what brokerages have to say about Dr. Reddy’s fourth-quarter results.
Palm oil has lost a pillar of support after Indonesia lifted a ban on exports, paving the way for prices to slump further.
How the portfolios of India's best-known equity investors changed in the March quarter.
Dr. Reddy’s net profit stood at Rs 97 crore in the three months ended March, down 83% over a year ago.